A dominant activating RAC2 variant associated with immunodeficiency and pulmonary disease

Clin Immunol. 2020 Mar:212:108248. doi: 10.1016/j.clim.2019.108248. Epub 2019 Aug 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • B-Lymphocytes / immunology
  • Disease Progression
  • GTPase-Activating Proteins / metabolism
  • Gain of Function Mutation
  • Graft vs Host Disease / drug therapy
  • Guanosine Triphosphate / metabolism
  • Hematopoietic Stem Cell Transplantation
  • Heterozygote
  • Humans
  • Immunologic Memory / immunology
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Lung Diseases / genetics*
  • Lung Diseases / immunology
  • Lung Diseases / physiopathology
  • Lung Diseases / surgery
  • Lung Transplantation
  • Lymphopenia / genetics*
  • Lymphopenia / immunology
  • Male
  • Molecular Docking Simulation
  • Neutrophils
  • Primary Immunodeficiency Diseases / genetics*
  • Primary Immunodeficiency Diseases / immunology
  • Primary Immunodeficiency Diseases / therapy
  • RAC2 GTP-Binding Protein
  • Recurrence
  • Respiratory Tract Infections / immunology
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocytes / immunology
  • rac GTP-Binding Proteins / genetics*
  • rac GTP-Binding Proteins / immunology
  • rac GTP-Binding Proteins / metabolism
  • rac GTP-Binding Proteins / ultrastructure

Substances

  • GTPase-Activating Proteins
  • Immunosuppressive Agents
  • mgcRacGAP
  • Guanosine Triphosphate
  • rac GTP-Binding Proteins